1014 250 mg (Levetiracetam 250 mg)

Pill imprint 1014 250 mg has been identified as Levetiracetam 250 mg.

Levetiracetam is used in the treatment of seizures; epilepsy; bipolar disorder; neuralgia; new daily persistent headache (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 1014 250 mg

Levetiracetam 250 mg 1014 250 mg
Levetiracetam
Imprint:
1014
250 mg
Strength:
250 mg
Color:
Blue
Size:
13.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Pyrrolidine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Torrent Pharmaceuticals
National Drug Code (NDC):
13668-0014
Inactive Ingredients:
silicon dioxide colloidal
FD&C Blue No. 2
hypromelloses
magnesium stearate
polyethylene glycol 400
povidone k30
sodium starch glycolate type A potato
pregelatinized corn starch
magnesium silicate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
16590-0320 Stat RX USA LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)